Neurology® Podcast

Dr. Greg Cooper talks with Dr. Elisabeth Kurpershoek about how clinicians communicate uncertainty during Parkinson disease diagnosis and how this impacts patient trust and understanding.

Read the related article in Neurology® Clinical Practice.

Disclosures can be found at Neurology.org.

The July 2026 Recall features four previously posted episodes related to updates in epilepsy. The episode opens with Dr. Rosemary Dray-Spira discussing trends in prenatal exposure to antiseizure medications over the past decade. The episode continues with Dr. Page Pennell discussing antiseizure medication management during pregnancy and postpartum. The episode then transitions into a conversation with Dr. Matthew Ryan Woodward on the complexities of status epilepticus, focusing on its definitions, the transition to refractory and super-refractory states, and the implications for treatment. In the final episode, Dr. Stefano Meletti discusses the incidence and characteristics of postictal central apnea in focal seizures.

Podcast links:

Trends in Prenatal Exposure to Antiseizure Medications

Antiseizure Medication Dosing Strategy During Pregnancy and Early Postpartum in Women With Epilepsy in MONEAD

Super Refractory Status Epilepticus Diagnosis, Management, and Prognostication

Persistent Postictal Central Apnea in Focal Seizures

Article links:

Trends in Prenatal Exposure to Antiseizure Medications Over the Past Decade A Nationwide Study

Antiseizure Medication Dosing Strategy During Pregnancy and Early Postpartum in Women With Epilepsy in MONEAD

Super-Refractory Status Epilepticus Diagnosis, Management, and Prognostication

Persistent Postictal Central Apnea in Focal Seizures

Disclosures can be found at Neurology.org.

Dr. Katie Krulisky talks with Dr. Marcus Pinto about the diagnosis and management of hereditary ATTR amyloidosis.

Read the related article in Neurology®.

Disclosures can be found at Neurology.org.

Dr. Andy Southerland talks with Dr. Seemant Chaturvedi about recent research presented at the 2026 European Stroke Organization Conference.

Read more about TAPIS trial.

Read more about the ODEA-TIA trial.

Disclosures can be found at Neurology.org.

Dr. Shuvro Roy talks with Dr. Michael Levy about satralizumab for treating relapsing MOGAD, current management challenges, and the encouraging results of this new therapy.

Read more about this abstract.

Disclosures can be found at Neurology.org.

Dr. Jeff Ratliff talks with Dr. Gabriela Figueiredo Pucci about how participation in a social media community influenced PIF and career development among neurology trainees.

Read the related article in Neurology® Education.

Disclosures can be found at Neurology.org.

Dr. Stacey Clardy talks with Dr. John Ney about wait times for new neurology office visits among commercially insured persons in the United States.

Read the related article in Neurology®.

Disclosures can be found at Neurology.org.

Dr. Dan Ackerman talks with Dr. Reza Bavarsad Shahripour about the diagnostic performance of 4 major modalities: TCD, TTE, TEE, and cardiac CT in patients with embolic stroke of undetermined source.

Read the related article in Neurology® Clinical Practice.

Disclosures can be found at Neurology.org.

Dr. Shuvro Roy talks with Dr. Amanda L. Piquet about the efficacy and safety of miv-cel in patients with stiff person syndrome.

Read more about this abstract on the AAN website.

Disclosures can be found at Neurology.org.

In part two of this series, Dr. Andy Southerland talks with Dr. Dan Ackerman about a few rapid‑fire concepts from the 2026 guidelines, focusing on what is new and how emerging data may shape patient care.

Disclosures can be found at Neurology.org.